Earth Venture Capital (Earth VC), a global climate-focused VC firm, has made an undisclosed investment in German biotech startup Cambrium’s seed extension round.
Gradient Ventures anchored this round.
Also Read: Earth VC backs US nuclear energy startup Aalo Atomics
Cambrium develops sustainable biomaterials by fusing AI with biotechnology. It creates protein-based materials, the building blocks for sustainable alternatives to petrochemical products. Leveraging biotechnology and AI, the startup aims to produce biodegradable materials that replace conventional resources.
Its current focus includes NovaColl, a precision-fermented, skin-identical collagen for personal care, launching in 2024, and plastic-free leather alternatives for fashion, launching in 2025. These innovations cater to rising consumer demand for sustainable products.
The latest funding will expand Cambrium’s production capabilities and accelerate product development in personal care, fashion, and nutraceuticals. By 2025, Cambrium plans to introduce plastic-free leather alternatives and textile coatings.
Also Read: Earth VC joins US-based cultivated meat startup Orbillion Bio’s funding round
Since its founding in 2020, Cambrium has raised EUR 11 million in funding.
“Investing in Cambrium is a direct bet on the future of sustainable materials, which is expected to reach US$138 billion by 2030. Protein-based innovations like Cambrium’s are the game-changers we need to decarbonise industries,” said Tien Nguyen, Founding Partner at Earth VC.
The post Earth VC invests in Germany’s sustainable biomaterials startup Cambrium appeared first on e27.